Today's PR is a building block that validates the science and the company's pipeline. It should cause the price to rise as new investors take positions and existing investors choose to increase their holdings. Leo continues to build shareholder value which I am sure is giving those short lots to worry about. I look forward to a steady stream of news that will lay the groundwork for us to list on NASDAQ. Well done management. Go IPIX!!!
(5)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links